From December 13, 2023 to December 31, 2023, the company has repurchased 20,100 shares, representing 0.17% for CAD 0.18 million. With this, the company has completed the repurchase of 20,100 shares, representing 0.17% for CAD 0.18 million under the buyback announced on December 13, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 CAD | +0.55% | 0.00% | -1.30% |
May. 17 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
May. 17 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.30% | 78.75M | |
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- RX Stock
- News BioSyent Inc.
- Tranche Update on BioSyent Inc. (TSXV: RX)'s Equity Buyback Plan announced on December 13, 2023.